caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1598860397

NPI 1598860397

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where NPI 1598860397's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Peter Fumo
Nephrology · Philadelphia, PA
801,312
Spectra East, Inc.
Clinical Laboratory · Rockleigh, NJ
53235
RANGASWAMI, JANANI30281
Vincent Figueredo
Cardiology · Langhorne, PA
2865
City Of Philadelphia
Ambulance Service Provider · Philadelphia, PA
2459
Aman Amanullah
Cardiology · Philadelphia, PA
2350
Lawrence Freitas
Internal Medicine · Willow Grove, PA
2332
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
1725
RESCUE TECH INC1622
Nicholas Langan
Internal Medicine · Philadelphia, PA
1521
NPI 10735748441423
HORROW, MINDY1116
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.